MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
HomeMarketsNeurological

Neurological

Highlights
Synchron CEO Thomas Oxley holding the Stentrode Endovascular Electrode Array during TED 2022.
Brain-Computer Interface Tech Hits a Huge Milestone
Jul 19, 2022
Synchron, a rival to Elon Musk's Neuralink, has completed a first-in-human implant of its brain-computer interface device in the United States. The first U.S. human procedure was performed at Mount Sinai Health System in New York, NY.
Monteris Medical NeuroBlate technology for non-surgical treatment of glioblastoma.png
This Surgical Alternative for Recurrent Brain Tumors Is LITT
Jun 03, 2022
Post-market data shows laser interstitial thermal therapy (LITT) using Monteris Medical's NeuroBlate System offers an effective alternative to traditional surgery for patients with newly diagnosed and recurrent glioblastoma, a fast-growing and...
Load More